Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             19 results found
no title author magazine year volume issue page(s) type
1 Ablative treatments for locally advanced pancreatic cancer: the CROSSFIRE trial Westerhoff, Jasmijn Maria

9 8 p. 687
article
2 Ablative treatments for locally advanced pancreatic cancer: the CROSSFIRE trial: Authors' reply Timmer, Florentine E F

9 8 p. 687-688
article
3 Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial Kang, Yoon-Koo

9 8 p. 705-717
article
4 Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease Iacucci, Marietta

9 8 p. 758-772
article
5 Broadening clinical indications of tenofovir alafenamide in chronic hepatitis B Mak, Lung-Yi

9 8 p. 681-682
article
6 Considerations for treating autistic individuals in gastroenterology clinics Buie, Timothy

9 8 p. 684-686
article
7 Digestive Disease Week 2024 Thomas, Hugh

9 8 p. 690
article
8 Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study Oh, Do-Youn

9 8 p. 694-704
article
9 EASL Congress 2024 Brierley, Rob

9 8 p. 691
article
10 Immune-checkpoint blockade in surgical management of gastric or gastro-oesophageal junction adenocarcinoma Lowery, Maeve A

9 8 p. 679-681
article
11 Immunotherapy in biliary tract cancer: are we finally on the right path? Ricci, Angela Dalia

9 8 p. 678-679
article
12 Infections in cirrhosis Piano, Salvatore

9 8 p. 745-757
article
13 Nanoliposomal irinotecan and fluorouracil plus leucovorin versus fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies (AIO NALIRICC): a multicentre, open-label, randomised, phase 2 trial Vogel, Arndt

9 8 p. 734-744
article
14 Nanoliposomal irinotecan in advanced biliary tract cancers Malka, David

9 8 p. 683-684
article
15 No accident: the UK infected blood scandal The Lancet Gastroenterology & Hepatology,

9 8 p. 677
article
16 Research in Brief Baker, Holly

9 8 p. 692
article
17 Saturated Facts: the start of a preventive revolution? Haslam, Elizabeth

9 8 p. 693
article
18 Switching to tenofovir alafenamide in patients with virologically suppressed chronic hepatitis B and renal or hepatic impairment: final week 96 results from an open-label, multicentre, phase 2 study Janssen, Harry L A

9 8 p. 718-733
article
19 Time for a treat all approach for hepatitis B Halford, Rachel

9 8 p. 688-689
article
                             19 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands